filmov
tv
Sinovac's vaccine 'attractive option,' study finds
Показать описание
Sinovac’s experimental COVID-19 vaccine triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed.
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
0:18:39
0:04:55
0:13:00
0:01:20
0:00:49
0:01:21
0:01:03
0:02:16
0:01:11
0:06:30
0:00:51
0:03:19
0:09:16
0:02:35
0:02:16
0:00:46
0:00:40
0:03:35
0:02:28
0:01:52
0:09:49
0:00:33
0:03:53
0:02:19